Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD. Swiss Med Wkly [Internet]. 2012 Jul. 15 [cited 2025 Oct. 20];142(2930):w13628. Available from: https://www.smw.ch/index.php/smw/article/view/1535